Susan Dubé is vice president, business development and administration of Amplyx Pharmaceuticals, Inc. Previously Susan served as the vice president, corporate development at Lumena Pharmaceuticals, Inc. until its acquisition by Shire plc in June 2014. Susan has over 30 years of experience in the life science industry and has held senior positions at a number of companies including co-founder and senior vice president, corporate development at Somaxon Pharmaceuticals, Inc., senior vice president of corporate development at Women First HealthCare, senior vice president, strategy and corporate development at Imagyn Medical Technologies, Inc., vice president of marketing and corporate development at Imagyn Medical, Inc., chief operating officer of Adeza Biomedical Corporation and vice president, ventures at the Brigham and Women’s Hospital. Ms. Dubé holds an M.B.A. from Harvard University and a B.A. in government from Simmons College. Susan Dubé is vice president, business development and administration of Amplyx Pharmaceuticals, Inc. Previously Susan served as the vice president, corporate development at Lumena Pharmaceuticals, Inc. until its acquisition by Shire plc in June 2014. Susan has over 30 years of experience in the life science industry and has held senior positions at a number of companies including co-founder and senior vice president, corporate development at Somaxon Pharmaceuticals, Inc., senior vice president of corporate development at Women First HealthCare, senior vice president, strategy and corporate development at Imagyn Medical Technologies, Inc., vice president of marketing and corporate development at Imagyn Medical, Inc., chief operating officer of Adeza Biomedical Corporation and vice president, ventures at the Brigham and Women’s Hospital. Ms. Dubé holds an M.B.A. from Harvard University and a B.A. in government from Simmons College.

Business